Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cell conditioned medium for pain in pancreaticobiliary maljunction cholangitis
jRCT1051240232Recruiting
- Sponsor
- Kawagoe Chuo Clinic
- Start
- Apr 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human-derived mesenchymal stem cell conditioned medium in cholangiolitis, sponsored by Kawagoe Chuo Clinic. Started Apr 2024; status: recruiting.
02
Drugs
human-derived mesenchymal stem cell conditioned medium
03
Conditions
cholangiolitis
Beyond the preview
Go deeper on jRCT1051240232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240232.